News - Ipsen, Mergers & Acquisitions


Popular Filters

Ipsen and Inspiration Biopharma sell IB1001 rights to Cangene


French drugmaker Ipsen (Euronext: IPN) and privately-held Inspiration Biopharmaceuticals entered into…

Cangene CorpIB1001Inspiration BiopharmaceuticalsIpsenMergers & AcquisitionsPharmaceutical

Ipsen and Inspiration Biopharma in deal with Baxter for OBI-1


French drugmaker Ipsen (Euronext: IPN) and privately-held US firm Inspiration Biopharmaceuticals have…

Baxter InternationalIB1001Inspiration BiopharmaceuticalsIpsenMergers & AcquisitionsOBI-1Pharmaceutical

Ipsen sells North American rights for Apokyn to Britannia Pharma


French drugmaker Ipsen (Euronext: IPN) today has sold its North American development and marketing rights…

ApokynBritannia PharmaceuticalsIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSTADA Arzneimittel

Back to top